A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...
Chinese scientists have created a safe and efficient method for transplanting mitochondria — the powerhouse resident of cells containing DNA — in a way that promises to significantly improve symptoms ...
The current Middle East conflict could escalate rapidly, potentially driving oil prices (CO1:COM), (CL1:COM) above $200 per ...
An American tech chief executive reveals how he developed his own software to prevent other cancers like his being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results